Evolent Health Inc (EVH)
11.59
+0.28
(+2.48%)
USD |
NYSE |
Nov 21, 16:00
11.58
-0.01
(-0.09%)
Pre-Market: 08:10
Evolent Health Gross Profit Margin (Quarterly): 12.99% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 12.99% |
June 30, 2024 | 16.51% |
March 31, 2024 | 16.28% |
December 31, 2023 | 18.28% |
September 30, 2023 | 24.35% |
June 30, 2023 | 24.98% |
March 31, 2023 | 27.41% |
December 31, 2022 | 21.72% |
September 30, 2022 | 24.38% |
June 30, 2022 | 21.95% |
March 31, 2022 | 26.03% |
December 31, 2021 | 33.77% |
September 30, 2021 | 26.68% |
June 30, 2021 | 22.49% |
March 31, 2021 | 26.61% |
December 31, 2020 | 29.08% |
September 30, 2020 | 24.13% |
June 30, 2020 | 24.36% |
March 31, 2020 | 20.61% |
December 31, 2019 | -101.2% |
September 30, 2019 | 40.15% |
June 30, 2019 | 43.54% |
Date | Value |
---|---|
March 31, 2019 | 40.61% |
December 31, 2018 | 41.54% |
September 30, 2018 | 50.67% |
June 30, 2018 | 52.18% |
March 31, 2018 | 48.48% |
December 31, 2017 | 42.36% |
September 30, 2017 | 36.73% |
June 30, 2017 | 36.50% |
March 31, 2017 | 36.44% |
December 31, 2016 | 31.96% |
September 30, 2016 | 43.69% |
June 30, 2016 | 42.00% |
March 31, 2016 | 42.14% |
December 31, 2015 | 46.27% |
September 30, 2015 | 38.72% |
June 30, 2015 | 24.27% |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | 26.18% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-101.2%
Minimum
Dec 2019
33.77%
Maximum
Dec 2021
17.07%
Average
24.24%
Median
Gross Profit Margin (Quarterly) Benchmarks
Astrana Health Inc | 15.35% |
American Shared Hospital Services | 19.57% |
Cryo-Cell International Inc | 73.65% |
P3 Health Partners Inc | -- |
Biote Corp | 70.47% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -6.81% |
Return on Assets | -2.78% |
Return on Invested Capital | -4.35% |
Profit Margin (Quarterly) | -3.72% |
Operating Margin (Quarterly) | -2.59% |
Return on Net Operating Assets | -3.07% |